Compare AVAH & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAH | ATRC |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2021 | 2005 |
| Metric | AVAH | ATRC |
|---|---|---|
| Price | $7.30 | $31.64 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $10.56 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 1.0M | 811.4K |
| Earning Date | 04-22-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.55 | 74.74 |
| EPS | ★ 0.22 | N/A |
| Revenue | ★ $2,024,506,000.00 | $201,630,000.00 |
| Revenue This Year | $21.81 | $14.90 |
| Revenue Next Year | $5.96 | $12.87 |
| P/E Ratio | $33.70 | ★ N/A |
| Revenue Growth | 6.82 | ★ 15.40 |
| 52 Week Low | $3.67 | $28.32 |
| 52 Week High | $10.32 | $43.18 |
| Indicator | AVAH | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 38.16 | 36.41 |
| Support Level | $3.81 | $30.06 |
| Resistance Level | $8.54 | $34.59 |
| Average True Range (ATR) | 0.30 | 1.73 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 26.64 | 40.85 |
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.